Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) has a relatively limited number of clinically significant drug interactions, but there are specific medicines and situations where your prescriber needs the full picture before treatment starts. The biggest misconception is that because tirzepatide is an injection rather than a tablet, it sidesteps the interactions that oral medicines cause. It doesn't — and the reason matters more than the myth. Mounjaro slows gastric emptying, which affects how quickly other medicines leave your stomach and enter your bloodstream. That change can shift the absorption timing of certain co-prescribed drugs, enough to be clinically relevant. As a prescription-only medicine, every course of tirzepatide requires a full clinical assessment — a prescriber reviews your current medicines before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for Mounjaro drug interactions are worried about the same thing: they take several medicines and they've heard GLP-1 drugs can interfere with them all. The concern is understandable, but it overstates the risk for most people. Tirzepatide's main mechanism relevant here is the slowing of gastric emptying, food, and anything else in the stomach, moves into the small intestine more slowly. For some drugs, that's clinically irrelevant. For others, particularly those with a narrow therapeutic window or time-sensitive absorption, the timing shift matters.
The interaction isn't usually that tirzepatide stops another medicine working; it's that peak blood levels of the other drug arrive later than expected. For most long-acting medicines taken once daily (statins, ACE inhibitors, many antidepressants) that delay is unlikely to produce a meaningful clinical difference. The NHS medicines guidance on tirzepatide notes that drug interactions are possible via this mechanism, which is why a prescriber reviews your full medicine list at consultation. If you take something that could be affected, that review is where adjustments are made, not after treatment starts.
It is also worth knowing that tirzepatide interactions differ in important ways from those of GLP-1-only medicines like semaglutide. Tirzepatide is a dual GIP and GLP-1 receptor agonist. The interaction profile is similar in mechanism but not identical in magnitude across all drugs, so findings from older semaglutide studies aren't automatically transferable. For a thorough breakdown of tirzepatide's specific interaction evidence, the tirzepatide interactions with other drugs page covers the pharmacokinetic data in more detail.
A handful of drug interactions with Mounjaro are specific enough to need prescriber planning rather than general reassurance. These are the ones that regularly come up in clinical review:
Oral contraceptives. UK guidance (including NHS England's weight-management-injections guidance) advises that women taking oral hormonal contraceptives should use an additional non-oral method of contraception (such as condoms) during the first four weeks of Mounjaro treatment and for four weeks after every dose increase. The concern is that slower gastric transit could reduce pill absorption during those windows. Semaglutide doesn't carry the same formal recommendation. If this applies to you, it's the kind of thing worth flagging before your first pen, not after. The Mounjaro medication interactions page covers hormonal contraception in full.
Insulin and insulin-stimulating drugs. If you take insulin or a sulfonylurea (such as glipizide or gliclazide), adding tirzepatide increases the risk of hypoglycaemia, low blood sugar. This isn't a reason not to use these drugs together; it's a reason your prescriber will likely reduce insulin or sulfonylurea doses before starting Mounjaro, and monitor closely during early treatment. The Mounjaro SmPC sets this out clearly, and the does Mounjaro have any drug interactions page has more on the diabetes-drug picture specifically.
Narrow-therapeutic-index drugs. Medicines where small changes in blood levels produce large changes in effect (certain anticoagulants, some antiepileptics) warrant closer monitoring when you start or titrate tirzepatide. Your prescriber may ask you to get a blood test or check in with the team who manages that medicine. This is precautionary rather than a blanket contraindication.
Alcohol. Not a pharmacokinetic interaction in the classical sense, but alcohol lowers blood sugar and may worsen GI side effects on tirzepatide. Prescribers routinely flag this, and it is worth mentioning if alcohol is a regular part of your week.
Amitriptyline comes up often because it is widely prescribed at low doses for sleep, nerve pain and migraine prevention, and patients worry about combining it with a weight-loss injection. The interaction picture for amitriptyline and Mounjaro sits in the gastric-emptying category: the theoretical concern is that delayed absorption could affect amitriptyline levels, though this hasn't produced a formal contraindication. That said, amitriptyline also has its own weight and appetite effects, and prescribers will want to know you're on it. The amitriptyline and Mounjaro page gives a fuller account.
Other commonly asked-about medicines include metformin (generally unproblematic alongside tirzepatide), blood pressure drugs (fine to continue, with monitoring), and HRT. On HRT specifically: NHS England recommends considering transdermal forms (patches or gels) while on tirzepatide rather than oral HRT, again because of the absorption-timing question. Oral HRT is not prohibited, but it's a conversation worth having with whoever manages your HRT.
If you'd like to understand the drug interactions with tirzepatide from the perspective of what a GP would check, the does Mounjaro interact with medications page works through the clinical checklist. And for a look at where tirzepatide sits as a treatment option overall, the tirzepatide overview covers the broader picture.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives) a real clinician, not a filter algorithm. Part of that review is checking your declared medicines against tirzepatide's known interaction profile. The more complete your medicine list, the cleaner that check can be.
Bring everything: prescription drugs, OTC medicines, supplements (fish oil and St John's Wort both have relevance in GI and metabolic contexts), and anything you take intermittently. If you're on an oral contraceptive, note which one. If you inject insulin, note the type and dose. If you've recently been told to start a new medicine, mention it even if it hasn't started yet.
One practical point: if you do start Mounjaro and you keep other daily medicines on the fridge door alongside your pen, consider whether any of them are time-sensitive enough to warrant spacing the doses by 30–60 minutes, and ask your prescriber. It is a small logistical change but the kind of thing worth settling at the start.
The what drugs interact with Mounjaro page has an A-to-Z breakdown if you want to look up a specific medicine. For context on the best time to take Mounjaro in relation to your other medicines, that page covers scheduling and timing in detail. The BNF entry for tirzepatide, available via the BNF on the NICE website, lists the formal interaction categories for prescribers. If you'd like to start a clinical conversation about your own medicine list, speak to our prescribers, the consultation is free and reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.